Skip to content

Clinical trials

Completed Lymphoma, B-Cell trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, B-Cell Status: Completed Country / region: Netherlands Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20111
20131
20162
20171
20193

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
AstraZeneca1
Celgene1
Gustave Roussy, Cancer Campus, Grand Paris1
Janssen Research & Development, LLC1
Kite, A Gilead Company1
Merus B.V.1
Pfizer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, B-Cell9
Lymphoma, Large B-Cell, Diffuse4
Lymphoma3
Lymphoma, Non-Hodgkin3
Burkitt Lymphoma2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma, Follicular2
Recurrence2
Hodgkin Disease1
Immune System Diseases1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.